Related Experiment Videos
Three clinical methods of circulatory assistance
Insights
Three clinical circulatory assistance methods show hemodynamic effectiveness. Intra-aortic balloon counterpulsation suits cardiosclerosis, while left ventricular bypass and artificial ventricles aid specific post-surgery or critical care scenarios.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Biomedical Engineering
Background:
- Circulatory assistance is crucial for patients with severe heart conditions.
- Various mechanical devices aim to support or replace cardiac function.
Purpose of the Study:
- To describe and evaluate three clinical methods of circulatory assistance.
- To outline indications and contraindications for each method.
Main Methods:
- Intraaortic balloon counterpulsation (IABC).
- Left ventricular bypass (LVB) using a roller pump.
- Artificial ventricle (AV) support.
Main Results:
- All three methods demonstrated hemodynamic effectiveness.
- IABC is indicated for cardiosclerosis and coronary insufficiency, contraindicated in valvular disease.
- LVB showed temporary benefit in weaning from cardiopulmonary bypass.
- AV is effective for cardiogenic shock post-cardiac surgery.
Conclusions:
- Clinical circulatory assistance methods offer significant hemodynamic support.
- Method selection depends on specific patient pathology and clinical context.
- These devices play a vital role in managing critical cardiovascular conditions.
Abstract:
Three clinical methods of circulatory assistance are described: intraaortic balloon counterpulsation, left ventricular bypass using a roller pump, and the artificial ventricle. All three methods have hemodynamic effectiveness. The first method is indicated in cases of widespread cardiosclerosis and pronounced coronary insufficiency and may be contraindicated in pathology of the valvular apparatus. The second method demonstrated a temporary positive effect in patients in whom it was not possible to discontinue artificial circulation. The artificial ventricle is useful in treating patients with cardiogenic shock following cardiac surgery.